Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Pharma Intermediate. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN111675662B details a novel iron-catalyzed route for quinazolinones, offering significant cost reduction and scalability for API manufacturing supply chains.
Patent CN114456089B details a novel cobalt-catalyzed three-component reaction enabling efficient synthesis of amino-nitrile pharmaceutical intermediates with reduced costs.
Novel nickel-catalyzed method for ketone nitrile compounds reduces costs and improves supply chain reliability for pharmaceutical intermediates manufacturing significantly
Patent CN113121462A discloses a metal-free synthesis of 5-CF3 triazoles. A cost-effective, scalable route for high-purity pharmaceutical intermediates.
Patent CN113105402B reveals a metal-free iodine-promoted route for 3,4,5-trisubstituted 1,2,4-triazoles, offering significant cost reduction in API manufacturing and scalable production.
Patent CN118619879A reveals a novel Rhodium-catalyzed C-H activation route for trifluoromethyl enaminones, offering scalable supply chain solutions and cost efficiency.
Patent CN115340460B enables high-yield indole intermediate production with reduced time and enhanced supply chain reliability for global buyers.
Novel AlCl3-catalyzed route offers high stereoselectivity and mild conditions for scalable production of key pharmaceutical intermediates.
Patent CN111423381B reveals a mild palladium-catalyzed route to 2-trifluoromethyl imidazoles, offering reliable pharmaceutical intermediate suppliers a cost-effective manufacturing solution.
Novel FeCl2-catalyzed cyclization offers high-purity thieno[3,4-b]indole derivatives with simplified supply chains for photoelectric materials.
Patent CN105646382A reveals iodine-catalyzed synthesis offering cost reduction and scalable supply chain reliability for high-purity pharmaceutical intermediates.
Patent CN113880781B reveals glucose-based synthesis for triazoles offering cost reduction and supply chain reliability for pharmaceutical intermediate manufacturing processes globally.
Novel cobalt-catalyzed C-H carbonylation for indolo[1,2-a]quinazolin-6(5H)-ones. Cost-effective, scalable route for pharmaceutical intermediates.
Patent CN102659494A discloses a novel organocatalytic route for 3,3-disubstituted-2-oxindoles, offering high ee values and scalable manufacturing for pharmaceutical intermediates.
Novel radical amino migration patent enables mild benzolactam synthesis. Offers cost reduction and supply chain reliability for high-purity pharmaceutical intermediates manufacturing.
Patent CN112239436A details a novel Pd-catalyzed bis-carbonylation route for 4-acyl-2(5H)-furanones, offering high yields and simplified operations for API manufacturing.
Patent CN111978237A details a novel Cu-catalyzed four-component coupling for high-purity maleimide intermediates, offering significant cost reduction and supply chain reliability.
Novel DES-mediated synthesis of benzoxazine derivatives offers green, high-yield routes for pharmaceutical intermediates, reducing costs and environmental impact.
Novel carbonylation method using sulfonyl chlorides avoids toxic thiols. High purity thioesters for pharma intermediates with simplified supply chain.
Patent CN111675662B reveals a novel FeCl3-catalyzed route for quinazolinone derivatives. Discover cost-effective manufacturing and high-purity supply chain solutions.